Clinical trial

A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer

NCT07623356

StatusRECRUITING
Study typeINTERVENTIONAL
Start date2026-07-07
PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2026-07-07Date precision: day
Registry last updated2026-07-29
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Sponsors & collaborators

Akesolead sponsor

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.